CBS' in-house physician Jon LaPook completed a disapproving two-part series (here and here) on angioplasty, the surgical procedure for heart disease patients that inserts a stent to keep arteries open. "At about $16,000 a procedure it is a roughly $21bn-a-year industry," LaPook stated. And the doctor is no fan.
What is wrong? LaPook lists the ways. He zeroed in on non-emergency angioplasty, for those patients who are not suffering a heart attack. In such elective cases, one patient out of every 200 ends up dead. Yet medication such as Zocor or Lipitor is just as effective a treatment. An elective procedure neither prolongs the patient's life nor improves the odds of avoiding a heart attack. "The problem starts with consent forms," declared LaPook. They tend to use "confusing language; they are often missing specific risks; and are generally not well explained by doctors."
LaPook concluded with a report from Dartmouth University. It estimates that at least 30% of angioplasty patients would reject the procedure if they were properly informed. "The goal," the doctor told us, is "less risk and less waste."
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.